The incidence and predictors of thromboembolic events in patients with lung cancer
- PMID: 24574864
- PMCID: PMC3918375
- DOI: 10.1155/2014/125706
The incidence and predictors of thromboembolic events in patients with lung cancer
Abstract
Patients with lung cancer experience elevated risk of venous thromboembolism. Cancer patients with thrombosis have a shorter life expectancy and the occurrence of VTE worsens the quality of life and may delay, interrupt, or completely halt the cancer therapy. In a large cohort of lung cancer patients we monitored the incidence of venous thromboembolism and we identified groups of patients with the highest risk of venous thromboembolism suitable for antithrombotic prophylaxis, which could favourably affect their morbidity and mortality.
Figures
Similar articles
-
Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer.J Thorac Cardiovasc Surg. 2016 Jan;151(1):37-44.e1. doi: 10.1016/j.jtcvs.2015.08.039. Epub 2015 Aug 15. J Thorac Cardiovasc Surg. 2016. PMID: 26386868
-
Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.BMC Cancer. 2020 May 24;20(1):461. doi: 10.1186/s12885-020-06930-1. BMC Cancer. 2020. PMID: 32448219 Free PMC article.
-
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).Oncologist. 2018 Feb;23(2):247-255. doi: 10.1634/theoncologist.2017-0205. Epub 2017 Sep 26. Oncologist. 2018. PMID: 28951500 Free PMC article.
-
Venous thromboembolism and prophylaxis in cancer patients.Medicina (Kaunas). 2008;44(3):175-81. Medicina (Kaunas). 2008. PMID: 18413983 Review.
-
Primary venous thromboembolism prophylaxis in ambulatory cancer patients.Ann Pharmacother. 2013 Feb;47(2):198-209. doi: 10.1345/aph.1R335. Epub 2013 Feb 5. Ann Pharmacother. 2013. PMID: 23386067 Review.
Cited by
-
Cancer and Thrombosis: The Platelet Perspective.Front Cell Dev Biol. 2017 Jan 5;4:147. doi: 10.3389/fcell.2016.00147. eCollection 2016. Front Cell Dev Biol. 2017. PMID: 28105409 Free PMC article. Review.
-
Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade.Cancers (Basel). 2024 Jan 20;16(2):450. doi: 10.3390/cancers16020450. Cancers (Basel). 2024. PMID: 38275891 Free PMC article. Review.
-
[Value of Coagulation and Fibrinolysis Biomarker in Lung Cancer Patients with Thromboembolism].Zhongguo Fei Ai Za Zhi. 2018 Aug 20;21(8):583-587. doi: 10.3779/j.issn.1009-3419.2018.08.03. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30172264 Free PMC article. Chinese.
-
Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis.Diagnostics (Basel). 2022 Nov 25;12(12):2954. doi: 10.3390/diagnostics12122954. Diagnostics (Basel). 2022. PMID: 36552961 Free PMC article.
-
Perioperative factors and 30-day major complications following radical cystectomy: A single-center study in Thailand.Heliyon. 2024 Jun 22;10(13):e33476. doi: 10.1016/j.heliyon.2024.e33476. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39027524 Free PMC article.
References
-
- Trousseau A. Phlegmasia Alba Dolens. London, UK: Clinique Medicale de l’Hotel Dieu de Paris; 1865.
-
- Leclerc J. Venous Thromboembolic Disorders. Philadelphia, Pa, USA: Lea & Febiger; 1991.
-
- Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine. 1992;232(2):155–160. - PubMed
-
- Falanga A. The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment. Cancer Investigation. 2009;27(1):105–115. - PubMed
-
- Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. American Journal of Medicine. 2006;119(1):60–68. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical